Studies in schizophrenia: Pathophysiology and treatment

Dialogues in Clinical Neuroscience

Volumn 4, Issue 4, 2002, Pages 432-437

  Tamminga, Carol A ^a   Medoff, Deborah R ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Anterior cingulate cortex; Antipsychotic medication; Hippocampus; Limbic cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; CLOZAPINE; DOPAMINE; FLUORODEOXYGLUCOSE F 18; GLUTAMIC ACID; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENCYCLIDINE;

AUDITORY DISCRIMINATION; BRAIN; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FUNCTIONAL DISEASE; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; MEDICAL LITERATURE; NERVE CONDUCTION; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE;

EID: 0038669298     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Tamminga CA, Thaker GK, Medoff DR. Neuropsychiatric aspects of schizophrenia. In: Yudofsky SC, Hales RE, eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. Washington, DC: American Psychiatric Press; 2002:989-1020.
2. A receptor binding in the hippocampal formation of schizophrenic brain. Synapse. 1996;22:338-349.
3. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry. 2000;157:1141-1149.
4. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
5. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DLFAJ, Alpert NM. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature. 1998;1:318-323.
6. Harrison PJ, Eastwood SL. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet. 1998;352:1669-1673.
7. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122(Pt 4):593-624.
8. Benes FM. Neurobiological investigations in cingulate cortex of schizophrenic brain [Review]. Schizophr Bull. 1993;19:537-549.
9. Holcomb HH, Lahti AC, Weiler M, Medoff DR, Tamminga CA. Neuroleptic treatment of schizophrenic patients: how do haloperidol and clozapine normalize brain blood flow patterns associated with a difficult tone recognition task? In: Gattz WF, Hafner H, eds. Search for the Causes of Schizophrenia. Vol IV. Balance of the Century. Darmstadt, Germany: Steinkopff Verlag; 1999:355-365.
10. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 2001:543-550.
11. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatry. 2000;157:1634-1645.
12. Martin SP, Grimwood PD, Morris RGM. Synaptic plasticity and memory: an evaluation of the hypothesis. In: Cowan WM, Shooter EM, Stevens CF, Thompson RF, eds. Annual Review of Neuroscience. Palo Alto, Calif: Annual Reviews; 2000:649-712.
13. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry. In press.
14. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry. 1996;153:41-49.
15. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex [Review]. Annu Rev Neurosci. 1986;9:357-381.
16. Tamminga CA. Principles of the pharmacotherapy of schizophrenia. In: Bunney BS, ed. Neurobiology of Psychiatric Disorders. New York, NY: Oxford University Press; 1998:272-285.
17. Gao XM, Hashimoto T, Tamminga CA. Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse. 1998;29:14-28.
18. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 1995;13:9-19.